Habte Yimer, MD, Speculates on the Future of Anti-BCMA CAR-T Cell Therapy
Publication: Oncology Business Review
12/14/2018
Habte Yimer, hematologist and medical oncologist with Texas Oncology–Tyler, shares thoughts on whether anti-BCMA CAR-T cell therapy looks promising as a treatment option for multiple myeloma patients.
Click here to watch the full story.
Related Physicians